FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs

FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 22, 2016
New Immunohematology System from Ortho Clinical Diagnostics Expands ORTHO VISION® Platform; Now Commercially Available in the United States

RARITAN, NJ – October 22, 2016 – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO VISION® Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, received 510(k) clearance, signifying its conformity with U.S. Food and Drug Administration regulation. ORTHO VISION Max is now commercially available in the United States, and is also commercially available in Europe and Japan.  
The ORTHO VISION® Max launch follows the 2015 release of the ORTHO VISION® Analyzer, an instrument designed for small- to mid-sized transfusion labs. Together the analyzers form the ORTHO VISION® platform, which builds on Ortho Clinical Diagnostics’ proven track record of innovation in the transfusion medicine industry by delivering the only integrated instrument suite that’s part of a larger portfolio of products and services. Tailoring to the needs of any facility, the ORTHO VISION platform improves workflow and standardizes systems and processes, helping blood banks labs keep pace with growing industry pressure to increase productivity while remaining operationally efficient. 

“Labs are continuously pushed to accomplish more with fewer resources – including staff – and Ortho can now ease those pressures in labs of every size and makeup,” said Robert Yates, chief operating officer, Ortho Clinical Diagnostics. “Whether they perform 15 tests per day or 150, the ORTHO VISION platform helps labs better manage their contribution to the overall critical-care path.”

ORTHO VISION Max was developed for labs conducting greater than 50 types and screens per day, and it also supports more complex immunohematology testing such as serial dilutions for titration studies, reflex tests and selected cell antibody identification. The flexibility and responsiveness of the system allow the transfusion medicine department to process routine samples and STAT orders as they are received, rather than waiting for a complete batch before running the instrument. The ORTHO VISION platform’s ability to manage unpredictable workflow paired with its standardization benefits improve lab efficiency and, most importantly, patient care.

“Transfusion medicine departments are now focused not only on testing, but on connecting their work to patient outcomes,” said Heidi Casaletto, head of transfusion medicine at Ortho Clinical Diagnostics. “A comprehensive portfolio of products operating on a single platform means engaging with one user interface, ordering one set of consumables, one set of process and procedures and streamlining training for everyone in the department. It also means more rapid delivery of actionable results that would increase the efficiency of patient diagnosis and a recommended treatment plan.” 

About the ORTHO VISION Platform

Developed in direct partnership with transfusion medicine specialists, the ORTHO VISION platform offers a comprehensive suite of products for both individual and multi-site health network hospitals. Producing reliable and consistent results, the ORTHO VISION platform can be trusted by lab professionals to monitor and efficiently manage curves and shifts in workflow without needing adjustment. 

With an instrument that automates more tests than ever before, technicians can spend less time on the bench and optimize their skills to focus on other critical tasks.

ORTHO VISION Max is also commercially available in Europe and Japan. 

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 120 countries, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world, helping them run more efficiently and effectively, and improve patient care. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com

ORTHO VISION and ORTHO VISION Max are trademarks of Ortho Clinical Diagnostics.  

© Ortho Clinical Diagnostics 2016

Press Contact:

Renee Giello
Ortho Clinical Diagnostics
© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.